Clinical Trials Browser

deucravacitinib × Lymphoid × 1 year × Clear all

NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Lymphoma, Follicular, Psoriasis